GGrantIndex
← Search

NEW GENERATION PRECISION MEDICINES: BIOMARKER-TARGETED TR3 BIOLOGICS OVERCOME TREATMENT RESISTANCE IN OVARIAN CANCER

$686,236FY2017Department of the ArmyDOD

Washington University, The

Investigators

View source on USAspending →
NEW GENERATION PRECISION MEDICINES: BIOMARKER-TARGETED TR3 BIOLOGICS OVERCOME TREATMENT RESISTANCE IN OVARIAN CANCER · GrantIndex